Factors affecting long-term efficacy of T regulatory cell-based therapy in type 1 diabetes.
about
An epitope-specific DerG-PG70 LEAPS vaccine modulates T cell responses and suppresses arthritis progression in two related murine models of rheumatoid arthritisCell-Based Therapies with T Regulatory Cells.Mild hypothermia provides Treg stability.Engineered Tolerance: Tailoring Development, Function, and Antigen-Specificity of Regulatory T Cells.Harnessing the power of regulatory T-cells to control autoimmune diabetes: overview and perspective.The role of regulatory T cells and genes involved in their differentiation in pathogenesis of selected inflammatory and neoplastic skin diseases. Part III: Polymorphisms of genes involved in Tregs' activation and function.Minimum Information about T Regulatory Cells: A Step toward Reproducibility and Standardization.CD137+CD154- Expression As a Regulatory T Cell (Treg)-Specific Activation Signature for Identification and Sorting of Stable Human Tregs from In Vitro Expansion Cultures.Cell banking for regulatory T cell-based therapy: strategies to overcome the impact of cryopreservation on the Treg viability and phenotype.Immunological Profile and Predisposition to Autoimmunity in Girls With Turner Syndrome.Intradermal injection of low dose human regulatory T cells inhibits skin inflammation in a humanized mouse model.Adoptive transfer of xenoantigen‑stimulated T cell receptor Vβ‑restricted human regulatory T cells prevents porcine islet xenograft rejection in humanized mice
P2860
Q38674546-5B2CEE5C-2FB7-480C-A53F-E4D9562403A7Q38766028-00810462-C1C9-4C39-A89C-DA856D996F73Q41696924-4EFA8A6E-3115-476D-8EF2-23F0F19009A3Q47150746-4186650A-290B-4AEF-9EDE-58C80C52E9ABQ47385058-DB5FDE0E-B7ED-4515-B45B-6082A02BCF74Q49391905-F34AFE52-552B-4AB0-B986-D990095CE88BQ49403463-53C44872-BA49-494E-8EFF-4F8003FA7F1AQ50281162-89B85CD8-3C1F-442B-8151-7910362D2B89Q52668207-9AAE509B-3D88-4CD2-AA37-251D1591B503Q55264164-59F4D7AA-2CA7-4D68-B7B5-71CF185EE57FQ55667006-F1B00F32-EBD3-49D2-AF57-D771C51C48FEQ58752977-50054363-C972-458B-872B-5BD1A1BC4187
P2860
Factors affecting long-term efficacy of T regulatory cell-based therapy in type 1 diabetes.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Factors affecting long-term ef ...... ed therapy in type 1 diabetes.
@en
Factors affecting long-term ef ...... ed therapy in type 1 diabetes.
@nl
type
label
Factors affecting long-term ef ...... ed therapy in type 1 diabetes.
@en
Factors affecting long-term ef ...... ed therapy in type 1 diabetes.
@nl
prefLabel
Factors affecting long-term ef ...... ed therapy in type 1 diabetes.
@en
Factors affecting long-term ef ...... ed therapy in type 1 diabetes.
@nl
P2093
P2860
P50
P1476
Factors affecting long-term ef ...... sed therapy in type 1 diabetes
@en
P2093
Agnieszka Szadkowska
Anna Jaźwińska-Curyłło
Artur Bossowski
Hanna Zielińska
Ilona Derkowska
Krystyna Wyka
Magdalena Żalińska
Marcelina Grabowska
Mateusz Gliwiński
Małgorzata Myśliwiec
P2860
P2888
P356
10.1186/S12967-016-1090-7
P50
P577
2016-12-01T00:00:00Z
P6179
1020677285